Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Growth Inhibitory Activity of Honokiol through Cell-cycle Arrest, Apoptosis and Suppression of Akt/mTOR Signaling in Human Hepatocellular Carcinoma Cells

  • Received : 2013.05.26
  • Accepted : 2013.06.20
  • Published : 2013.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Honokiol, a naturally occurring neolignan mainly found in Magnolia species, has exhibited a potential anti-proliferative activity in human cancer cells. However, the growth inhibitory activity against hepatocellular carcinoma cells and the underlying molecular mechanisms has been poorly determined. The present study was designed to examine the anti-proliferative effect of honokiol in SK-HEP-1 human hepatocellular cancer cells. Honokiol exerted anti-proliferative activity with cell-cycle arrest at the G0/G1 phase and sequential induction of apoptotic cell death. The cell-cycle arrest was well correlated with the down-regulation of checkpoint proteins including cyclin D1, cyclin A, cyclin E, CDK4, PCNA, retinoblastoma protein (Rb), and c-Myc. The increase of sub-G1 peak by the higher concentration of honokiol ($75{\mu}M$) was closely related to the induction of apoptosis, which was evidenced by decreased expression of Bcl-2, Bid, and caspase-9. Hohokiol was also found to attenuate the activation of signaling proteins in the Akt/mTOR and ERK pathways. These findings suggest that the anti-proliferative effect of honokiol was associated in part with the induction of cell-cycle arrest, apoptosis, and dow-nregulation of Akt/mTOR signaling pathways in human hepatocellular cancer cells.

Keywords

References

  1. Alexander, A., Cai, S.L., Kim, J., Nanez, A., Sahin, M., MacLean, K.H., Inoki, K., Guan, K.L., Shen, J., Person, M.D., Kusewitt, D., Mills, G.B., Kastan, M.B., and Walker, C.L., ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl. Acad. Sci. U.S.A. 107, 4153-4158 (2010). https://doi.org/10.1073/pnas.0913860107
  2. Bosch, F.X., Ribes, J., Diaz, M., and Cleries, R., Primary liver cancer: worldwide incidence and trends. Gastroenterology 127, S5-S16 (2004). https://doi.org/10.1053/j.gastro.2004.09.011
  3. Cui, H.S., Huang, L.S., Sok, D.E., Shin, J., Kwon, B.M., Youn, U.J., and Bae, K., Protective action of honokiol, administered orally, against oxidative stress in brain of mice challenged with NMDA. Phytomedicine 14, 696-700 (2007). https://doi.org/10.1016/j.phymed.2007.03.005
  4. Fried, L.E. and Arbiser, J.L., Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid. Redox Signal. 11, 1139-1148 (2009). https://doi.org/10.1089/ars.2009.2440
  5. Han, S.J., Bae, E.A., Trinh, H.T., Yang, J.H., Youn, U.J., Bae, K.H., and Kim, D.H., Magnolol and honokiol: inhibitors against mouse passive cutaneous anaphylaxis reaction and scratching behaviors. Biol. Pharm. Bull. 30, 2201-2203 (2007). https://doi.org/10.1248/bpb.30.2201
  6. Hussain, S.A., Ferry, D.R., EL-Gazzaz, G., Mirza, D.F., James, N.D., McMaster, P., and Kerr, D.J., Hepatocellular carcinoma. Ann. Oncol. 12, 161-172 (2001). https://doi.org/10.1023/A:1008370324827
  7. Jo, S.K., Hong, J.Y., Park, H.J., and Lee, S.K., Anticancer activity of novel daphnane diterpenoids from Daphne genkwa through cell-cycle arrest and suppression of Akt/STAT/Src signaling in human lung cancer cells. Biomol. Ther. 20, 513-519 (2012). https://doi.org/10.4062/biomolther.2012.20.6.513
  8. Kang, Y.J., Chung, H.J., Min, H.Y., Song, J., Park, H.J., Youn, U.J., Bae, K.H., Kim, Y.S., and Lee, S.K., G0/G1 cell cycle arrest and activation of caspases in honokiol-mediated growth inhibition of human gastric cancer cells. Nat. Prod. Sci. 18, 16-21 (2012).
  9. Kang, Y.J., Min, H.Y., Hong, J.Y., Kim, Y.S., Kang, S.S., and Lee, S.K., Ochnaflavone, a natural biflavonoid, induces cell cycle arrest and apoptosis in HCT-15 human colon cancer cells. Biomol. Ther. 17, 282-287 (2009). https://doi.org/10.4062/biomolther.2009.17.3.282
  10. Kastan, M.B. and Bartek, K., Cell-cycle checkpoints and cancer. Nature 432, 316-323 (2004). https://doi.org/10.1038/nature03097
  11. Kudo, M., mTOR inhibitor for the treatment of hepatocellular carcinoma. Dig. Dis. 29, 310-315 (2011). https://doi.org/10.1159/000327565
  12. Nagono, H., Treatment of advanced hepatocellular carcinoma: intraarterial infusion chemotherapy combined with interferon. Oncology 78, 142-147 (2010). https://doi.org/10.1159/000315243
  13. Park, E.J., Min, H.Y, Chung, H.J., Hong, J.Y., Kang, Y.J., Hung, T.M., Youn, U.J., Kim, Y.S., Bae, K.H., Kang, S.S., and Lee, S.K., Downregulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett. 227, 133-140 (2009).
  14. Pelengaris, S., Khan, M., and Evan, G., c-Myc: more than just a matter of life and death. Nat. Rev. Cancer 2, 764-776 (2002). https://doi.org/10.1038/nrc904
  15. Schwartz, G.K. and Shah, M.A., Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol. 23, 9408-9421 (2005). https://doi.org/10.1200/JCO.2005.01.5594
  16. Shen, J.L., Man, K.M., Huang, P.H., Chen, W.C., Chen, D.C., Cheng, Y.W., Liu, P.L., Chou, M.C., and Chen, Y.H., Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders. Molecules 15, 6452-6465 (2010). https://doi.org/10.3390/molecules15096452
  17. Tian, W., Xu, D., and Deng, Y.C., Honokiol, a multifunctional tumor cell death inducer. Pharmazie 67, 811-816 (2012).
  18. Wullschleger, S., Loewith, R., and Hall, M.N., TOR signaling in growth and metabolism. Cell 124, 471-484 (2006). https://doi.org/10.1016/j.cell.2006.01.016
  19. Zhang, P., Liu, X., Zhu, Y., Chen, S., Zhou, D., and Wang, Y., Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-kB activation and cytokine production of glial cells. Neurosci. Lett. 8, 123-127 (2013).
  20. Zhou, G., Lui, V.W., and Yeo, W., Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Future Oncol. 7, 1149-1167 (2011). https://doi.org/10.2217/fon.11.95